Log in or Sign up for Free to view tailored content for your specialty!
Infection News
‘Common and unique immune features’ in long COVID may lead researchers to treatments
Patients with long COVID symptoms demonstrate elevated levels of several inflammatory molecules — findings that could have important implications in both rheumatology and the search for a potential treatment for long COVID.
Targeted psoriatic arthritis therapies demonstrate low risk for serious infection
Serious infections were uncommon among patients with psoriatic arthritis exposed to targeted therapies for the first time in “a large and exhaustive” French cohort, according to data published in RMD Open.
Log in or Sign up for Free to view tailored content for your specialty!
Third COVID-19 vaccine dose beneficial for most immunocompromised patients
A third dose of COVID-19 vaccine can boost serological and T-cell response among most patients who are immunocompromised, according to data published in The Lancet Rheumatology.
Simplified lupus infection prediction score more accurate, feasible than previous version
The SLE Severe Infection Score-Revised, an updated score for predicting severe infections in systemic lupus erythematosus, is more accurate and feasible than the prior version, according to data published in Lupus Science & Medicine.
COVID-19 vaccine response drops significantly after 6 months in patients with IMIDs
COVID-19 antibodies are significantly reduced by 6 months post-vaccination among patients with immune-mediated inflammatory diseases, according to data published in The Journal of Rheumatology.
Henoch-Schönlein purpura incidence fell, rose with COVID-19 protective measures
Incidence of Henoch-Schönlein purpura waned and waxed significantly with the implementation and relaxation of non-pharmaceutical interventions against COVID-19, according to data published in JAMA Network Open.
Algorithm scans outpatient letters, identifies those who must ‘shield’ against COVID-19
An automated algorithm designed to identify rheumatology patients who need to “shield” against COVID-19 demonstrated results that matched the “gold standard” of manual review in the majority of cases, according to data.
Risk for post-acute sequelae of COVID-19 down among patients with SARDs
Since the beginning of the COVID-19 pandemic, there has been a “significant decrease” in the risk for post-acute sequelae of COVID-19 among patients with rheumatic diseases, according to data published in The Journal of Rheumatology.
Prolonged SARS-CoV-2 infections impact quarter of immunocompromised patients
Approximately 25% of patients with COVID-19 who are immunocompromised remain positive for the disease 21 days or more from initial onset, according to data published in The Lancet Microbe.
Patients with prior COVID-19 at higher risk for new-onset autoimmune inflammatory disease
Patients with a history of COVID-19 demonstrate a higher risk for new-onset autoimmune inflammatory rheumatic diseases, with greater infection severity linked to greater risk, according to data published in the Annals of Internal Medicine.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read